Triatomic Management LP - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 202 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2023. The put-call ratio across all filers is 1.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
Triatomic Management LP ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q1 2024$316,362
-40.5%
98,555
-9.2%
0.59%
-12.9%
Q4 2023$531,920
-5.1%
108,555
+5.5%
0.68%
+74.5%
Q3 2023$560,745
-31.0%
102,889
-15.1%
0.39%
-53.4%
Q2 2023$813,024
-21.0%
121,166
+4.0%
0.83%
+20.2%
Q1 2023$1,029,225
-36.1%
116,560
-44.7%
0.69%
-48.9%
Q4 2022$1,610,550
-26.0%
210,805
-31.1%
1.36%
+8.2%
Q3 2022$2,177,000
-18.5%
305,805
-7.3%
1.25%
-49.0%
Q2 2022$2,670,000
-35.2%
329,981
+11.1%
2.45%
-26.8%
Q1 2022$4,123,000
+113.2%
297,048
+330.9%
3.35%
+182.6%
Q4 2021$1,934,00068,9401.18%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q4 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 1,687,665$5,417,4055.10%
Rubric Capital Management LP 10,500,000$33,705,0001.00%
Triatomic Management LP 98,555$316,3620.59%
Pier Capital, LLC 1,103,441$3,542,0460.49%
Newtyn Management, LLC 623,690$2,002,0450.40%
VIKING GLOBAL INVESTORS LP 29,993,708$96,279,8030.36%
Matrix Capital Management Company, LP 11,572,590$37,148,0140.34%
Tejara Capital Ltd 269,014$863,5350.32%
Aristotle Atlantic Partners, LLC 2,992,563$9,606,1270.31%
DDD Partners, LLC 739,739$2,374,5620.29%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders